December 16, 2019 News Magazine

Orca Security scores $6.5M seed round to solve cloud native security

Orca Security, a startup based in Israel, announced a healthy $6.5 million seed round today led by YL Ventures, a firm that makes a living investing in Israeli security startups.

That’s a lot of money for a seed round, but the company, which is led by two former Check Point Security executives, is trying to solve a hard problem around securing applications in the cloud without an agent.

“Orca, as a cloud native security platform, secures both customers’ own cloud native and legacy apps migrated to the cloud without needing agents,” company co-founder and CEO Avi Shua explained. Instead, he says the company uses a concept called “SideScanning,” which he said, “comprehensively examines the entire deployed software stack, discovering vulnerabilities, outdated and deprecated software versions, misconfiguration and other risks.”

This approach works well in a cloud native world where developers are launching applications in the cloud in containers using Kubernetes to orchestrate the containers, precisely because of the agentless approach.

Screenshot of Orca dashboard.

The startup is going after established security vendors like Rapid7 and Tenable by attempting to build a more modern approach to cloud security, one that’s built from the ground up for cloud native constructs. “We didn’t just repurpose security software originally targeted at data center workloads. As such, we can analyze and secure customers’ own cloud-native workloads, migrated legacy workloads and hybrids of the two,” he said.

As a seed investment, it’s still very much early days for the company, which has a 15 person staff. With several Beta customers, the startup is looking for ways to build out the product and help customers solve the security problems related to modern software approaches. Today’s funding should help in that regard.

Palo Alto Networks to acquire container security startup Twistlock for $410M

Banner
Related Posts

China startup deals shrink as fundraising for investors plummets

July 16, 2019

July 16, 2019

Chinese startups continue to weather tough times as private investors, caught in a cash crunch, are concentrating money into fewer deals. China’s deal-making activity for startups in the six months ended June halved from a year ago to 1,910, according to data from consulting firm ChinaVenture’s research arm. The amount invested in domestic startups during the first half of 2019 plummeted 54% to $23.2 billion. The slide in startup investment comes as the money behind the money shrinks amid a cooling economy in China that is exacerbated by a trade war with the U.S. Fundraising for investors was already showing signs of slowdown a year earlier. In the first half of this year, private equity and venture capital firms in China secured 30% less than what they had raised over the same period a year ago, amounting to a total of $54.44 billion; 271 funds managed to raise, down 52%. That money from limited partners is also flowing to a small rank of investors. Twelve institutions accounted f..

Less than 1 year after launching its corporate card for startups, Brex eyes $2B valuation

May 29, 2019

May 29, 2019

Brex, the fintech business that’s taken the startup world by storm with its sought after corporate card tailored for entrepreneurs, is raising millions in Series D funding less than a year after it launched, TechCrunch has learned. Bloomberg reports Brex is raising at a $2 billion valuation, though sources tell TechCrunch the company is still in negotiations with both new and existing investors. Brex didn’t immediately respond to requests for comment. Kleiner Perkins is leading the round via former general partner Mood Rowghani, who left the storied venture capital fund last year to form Bond alongside Mary Meeker and Noah Knauf. As we’ve previously reported, the Bond crew is still in the process of deploying capital from Kleiner’s billion-dollar Digital Growth Fund III, the pool of capital they were responsible for before leaving the firm. Bond, which recently closed on $1.25 billion for its debut effort and made its first investment, is not participating in the round for Brex, sou..

Knotch raises $25M to help marketers collect data about their content

January 29, 2019

January 29, 2019

Knotch announced yesterday that it has raised $25 million in Series B funding. The round was led by New Enterprise Associates, with NEA’s Hilarie Koplow-McAdams joining the Knotch board of directors. Rob Norman, the former chief digital officer of ad giant GroupM is also joining the board. “Brands have a desire to understand the effectiveness of their digital content across all channels, a gap that hadn’t been filled before Knotch,” Koplow-McAdams said in a statement. “Our conviction around the Knotch platform and team is driven by their impressive traction and comprehensive product offerings. We’re thrilled to partner with Knotch as they continue their growth trajectory, providing transformative marketing intelligence at scale.” When we first wrote about Knotch back in 2012, it was a consumer product where people could share their opinions using a color scale. It might seem like a stretch go from that to a marketing and data company, but in fact Knotch still collects data using its..

Kencko chugs down $3.4M to help you get more fruit and vegetables in your diet

July 12, 2019

July 12, 2019

Kencko, a company that wants to help people eat more fruit and vegetables in their daily life, is entering feast mode after it announced a $3.4 million seed round for growth and product development. We profiled the company last year, but — for those who missed it — Kencko develops plant-based products that help people eat healthily without having to suffer the pain of horrible-tasting food or other extreme eating. That’s to say that its fruit drinks, the company’s first product, include the pulp and vitamins absent in pressed juice but come in a convenient sachet that has been flash-frozen and slow-dried to retain all the goodness. The company says that each packet, which is 20g and mixes with water, contains two of the five-a-day recommendation for fruit and vegetable servings. Right now, Kencko — which means health in Japanese — is selling the fruit drink with six flavor options. Founder and CEO Tomás Froes said the plan is to add as many as half a dozen new options before this yea..

ZenBusiness raises $15m to help founders launch and grow “worry-free”

September 25, 2019

September 25, 2019

There are two sides to starting a new business. On one side, entrepreneurs need creativity, imagination — a dream, essentially — to find, build, and market a new product to users and consumers. But on the other side, they have to deal with the regulatory state and all the minutia that comes with running any business in the 21st century. That includes such delightful topics as choosing a particular model for incorporation, ensuring that a business has the right licenses to operate, and tracking all the legal changes happening in 50 state legislatures every year. It can be inordinately complicated (and expensive!) to ensure that your business is ready and legal. That’s where ZenBusiness comes in. The Austin-based startup wants to empower entrepreneurs to build businesses large and small by dramatically simplifying the processes required to launch a business and then grow it. When I last chatted with the company 18 months ago, they had just raised a $4.5 million seed round and had laun..

With a fresh $10 million in the bank, DotLab hopes to bring endometriosis test to market

July 1, 2019

July 1, 2019

Thirty-three-year-old founder of personalized medicine company DotLab, Heather Bowerman, wants to shake up the women’s health industry with what she believes to be a better, cheaper, less painful test for endometriosis. Her company has just completed a Yale University -led validation study and raised $10 million in Series A funding from CooperSurgical, TigerGlobal Management, Luxor Capital Group and the law firm Wilson Sonsini Goodrich & Rosati to bring a new, non-invasive diagnostic test to market. Endometriosis is an often painful disorder in which tissue begins to grow outside of the uterus and into a woman’s ovaries, fallopian tubes and pelvis. The disease may affect up to one in 10 women of childbearing years and about half of all women who experience infertility, according to the U.S. Department of Health and Human Services. However, even with clear symptoms of the disease, doctors often try to test for endometriosis as a last resort. The only way currently to test for it is ..

At-home blood testing startup Baze rakes in $6 million from Nature’s Way

August 30, 2019

August 30, 2019

By now, the venture world is wary of blood testing startups offering health data from just a few drops of blood. However, Baze, a Swiss-based personal nutrition startup providing blood tests you can do in the convenience of your own home, collects just a smidgen of your sanguine fluid through an MIT manufactured device, which, according to the company, is in accordance with FDA regulations. The idea is to find out (via your blood sample) which vitamins you’re missing out on and are keeping you from living your best life. That seems to resonate with folks who don’t want to go into the doctor’s office and separately head to their nearest lab for testing. Most health professionals would agree it’s important to know if you are getting the right amount of nutrition — Vitamin D deficiency is a worldwide epidemic affecting calcium absorption, hormone regulation, energy levels and muscle weakness. An estimated 74% of the U.S. population does not get the required daily levels of Vitamin D. “..

Report: Zoom, the video conferencing company, may be a public company as early as April

February 22, 2019

February 22, 2019

The video conferencing company Zoom is aiming to file a public S-1 by the end of March, according to a new report in Business Insider that adds the company could go public as soon as April. Business Insider reported last month that Zoom had filed confidentially with the SEC to go public, just months after Reuters reported that the San Jose, Calif.-based company had chosen investment bank Morgan Stanley to lead its eventual IPO. We’ve reached out to the company for comment. Zoom was valued at $1 billion when it raised its last funding in 2017 in the form of a $100 million check from Sequoia Capital. Reuters sources have said they expect the company to be valued at several billion dollars at the IPO. The company, founded in 2011, has raised $145 million altogether, including from Emergence Capital and Horizons Ventures. Its earliest backers include Qualcomm Ventures, Yahoo founder Jerry Yang, WebEx founder Subrah Iyar and former Cisco SVP Dan Scheinman, who has been an active angel i..

Fabula AI is using social spread to spot ‘fake news’

February 6, 2019

February 6, 2019

UK startup Fabula AI reckons it’s devised a way for artificial intelligence to help user generated content platforms get on top of the disinformation crisis that keeps rocking the world of social media with antisocial scandals. Even Facebook’s Mark Zuckerberg has sounded a cautious note about AI technology’s capability to meet the complex, contextual, messy and inherently human challenge of correctly understanding every missive a social media user might send, well-intentioned or its nasty flip-side. “It will take many years to fully develop these systems,” the Facebook founder wrote two years ago, in an open letter discussing the scale of the challenge of moderating content on platforms thick with billions of users. “This is technically difficult as it requires building AI that can read and understand news.” But what if AI doesn’t need to read and understand news in order to detect whether it’s true or false? Step forward Fabula, which has patented what it dubs a “new class” of mac..

Daily Crunch: A big funding round for Boll & Branch

August 26, 2019

August 26, 2019

The Daily Crunch is TechCrunch’s roundup of our biggest and most important stories. If you’d like to get this delivered to your inbox every day at around 9am Pacific, you can subscribe here. 1. Bedding startup Boll & Branch raises $100M The company sells sustainably sourced sheets, pillows, mattresses and towels. Until now, it had only raised $12 million in outside capital. This new funding comes from L Catterton. CEO Scott Tannen compared Boll & Branch to the firm’s previous investments The Honest Company and Peloton — companies that “have become the winner in the startup competition” and are ready to “really become household names.” 2. Nvidia and VMware team up to make GPU virtualization easier Nvidia today announced that it has been working with VMware to bring its virtual GPU technology to VMware’s vSphere and VMware Cloud on AWS. 3. Megvii, the Chinese startup unicorn known for facial recognition tech, files to go public in Hong Kong Founded by three Tsinghua University gra..

CTO.ai’s developer shortcuts eliminate coding busywork

November 4, 2019

November 4, 2019

There’s too much hype about mythical “10X developers”. Everyone’s desperate to hire these ‘ninja rockstars’. In reality, it’s smarter to find ways of deleting annoying chores for the coders you already have. That’s where CTO.ai comes in. Emerging from stealth today, CTO.ai lets developers build and borrow DevOps shortcuts. These automate long series of steps they usually have to do manually thanks to integrations with GitHub, AWS, Slack, and more. CTO.ai claims it can turn a days-long process like setting up a Kubernetes cluster into a 15-minute task even sales people can handle. The startup offers both a platform for engineering and sharing shortcuts, and a service where it can custom build shortcuts for big customers. What’s remarkable about CTO.ai is that amidst a frothy funding environment, the 60-person team quietly bootstrapped its way to profitability over the past two years. Why take funding when revenue was up 400% in 18 months? But after a chance meeting aboard a plane con..

Max Q: SpaceX and Boeing gear up for commercial crew mission tests

November 3, 2019

November 3, 2019

Welcome back to Max Q, our weekly look at what’s happening in space and space startup news. This week was a bit more quiet than usual coming off of the amazingly over-packed International Astronautical Congress, but there were still some big moves that promise a lot more action to come before they year’s over – particularly in the race to fly American astronauts to space on a rocket launched from American soil once again. There’s also startup news, including how an entirely different kind of race – one to make stuff in space – could be a foundational moment that opens up entirely new areas of opportunity for entrepreneurs big and small. 1. SpaceX’s crucial parachute tests are going well SpaceX needs to nail one key ingredient before its Crew Dragon missions can proceed apace with people on board. Actually, it has to nail quite a few, but parachutes are a crucial one, and it has been developing the parachutes that will help Crew Dragon float back safely to Earth for years not. The t..

Startups Weekly: Will the real unicorns please stand up?

June 1, 2019

June 1, 2019

Hello and welcome back to Startups Weekly, a newsletter published every Saturday that dives into the week’s noteworthy venture capital deals, funds and trends. Before I dive into this week’s topic, let’s catch up a bit. Last week, I wrote about the sudden uptick in beverage startup rounds. Before that, I noted an alternative to venture capital fundraising called revenue-based financing. Remember, you can send me tips, suggestions and feedback to kate.clark@techcrunch.com or on Twitter @KateClarkTweets. Here’s what I’ve been thinking about this week: Unicorn scarcity, or lack thereof. I’ve written about this concept before, as has my Equity co-host, Crunchbase News editor-in-chief Alex Wilhelm. I apologize if the two of us are broken records, but I think we’re equally perplexed by the pace at which companies are garnering $1 billion valuations. Here’s the latest data, according to Crunchbase: “2018 outstripped all previous years in terms of the number of unicorns created and venture ..

Adobe acquires Allegorithmic, makers of the Substance texture tools

January 23, 2019

January 23, 2019

Adobe today announced that it has acquired Allegorithmic, the French company behind the Substance tools for creating textures that are widely used by AAA game creators, as well as visual effects artists, animators and designers. Over time, Adobe will bring many of Allegorithmic’s technologies to its various Creative Cloud tools, many of which already offer complementary tools. Beyond those integrations, though, what this acquisition is really about is the fact that 3D design and creating 3D content is becoming increasingly important for the creatives who use Adobe’s tools. With Adobe Dimension and, more recently, Project Aero for creating AR experiences, the company has started focusing on 3D, and this acquisition will bring both talent and technology to the company. It’s worth noting that Adobe previously invested in Allegorithmic and that Dimension already features integration with Substance, so today’s announcement has clearly been in the works for a while. As Adobe’s chief produ..

With $160 million in new funding, Freenome looks to commercialize its blood test to detect colorectal cancer

July 24, 2019

July 24, 2019

One of the major problems that technology companies working to find a cure for cancer need to solve is finding a safe, minimally invasive way to detect cancers early. Almost all cancer screening will eventually require a biopsy, but determining whether that’s necessary in the early stages of cancer can mean the difference between life and death. It’s one of the reasons why investors have spent hundreds of millions if not billions of dollars to find a reliable way to detect cancer from simple procedures like a blood draw. And why they’re investing over $160 million in the South San Francisco-based startup, Freenome. “If I could do it with less money and do it responsibly, I would,” says Gabriel Otte, Freenome’s founder and chief executive officer. Since the company launched in 2014 it has been developing a test that combines machine learning with the development of proprietary assays to test for different types of cancer. The company’s research started in prostate cancer, but it ha..

Comments
Leave a Reply

Your email address will not be published. Required fields are marked *